Sequencing and identification of microRNAs from a genome-wide expression profile in serum of esophageal squamous cell carcinoma

ZHANG Yan-ni,LI Yan-fang,WANG Cheng,GUAN Xiao-cui,CHEN Xi,ZENG Ke,ZHANG Chen-Yu,ZHANG Chun-ni

2012-01-01

Abstract:Objective To sequence and investigate microRNAs from a genome-wide serum microRNA(miRNA) expression profile to identify differentially expressed miRNAs in esophageal squamous cell carcinoma(ESCC) and explore the potential as a novel molecular biomarkers for ESCC.Methods Serum samples were taken from 199 ESCC patients and 107 age-and gender-matched healthy controls.The serum miRNAs were screened and sequenced by Solexa sequencing technology,and the expression levels of miRNAs were quantified.The upregulated miR-223 was confirmed by real-time quantitative PCR(RT-qPCR) assay.Results The Solexa data showed that the proportions of miRNA in the small RNAs of ESCC patients and healthy controls were 75.46% and 81.44% respectively,and 22 miRNAs were upregulated in ESCC more than double the controls.RT-qPCR confirmed that the concentration of miR-223 was significantly elevated in the serum from ESCC patients as compared with the controls[893.8(684.8,1 200.7) fmol/L vs 445.6(347.7,664.0) fmol/L,P<0.01].The area under ROC curve(AUC) of miR-223 for diagnosis of ESCC was 0.84(95% CI 0.79 to 0.89),which was significantly greater than that of carcinoembryonic antigen(0.55 for AUC,95%CI 0.48 to 0.62,P<0.01).When the cut-off value was defined as 710.2 fmol/L,sensitivity and specificity of miR-223 were high up to 70% and 80% for ESCC prediction.Conclusion The expression profile of serum miRNAs of ESCC patients was distinctive from healthy individuals and miR-223 concentration was significantly elevated in ESCC serum,which hold potential as novel noninvasive biomarker for diagnosis of ESCC.